|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.490 USD | +35.45% |
|
+35.45% | +17.14% |
| 07-28 | Essentra plc, H1 2026 Earnings Call, Jul 28, 2026 | |
| 07-28 | EARNINGS AND TRADING: Allergy Therapeutics names next executive chair | AN |
Company Valuation: Essentra plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,038 | 712 | 488.3 | 381.3 | 275 | 323.3 | - | - |
| Change | - | -31.4% | -31.42% | -21.91% | -27.87% | 17.55% | - | - |
| Enterprise Value (EV) 1 | 1,273 | 598.2 | 550.8 | 449.5 | 335.7 | 419.1 | 409.8 | 398.8 |
| Change | - | -52.99% | -7.92% | -18.39% | -25.31% | 24.82% | -2.22% | -2.67% |
| P/E | 38.8x | -3.79x | 94.2x | 35.9x | 138x | 134x | 25.6x | 18.8x |
| PBR | 1.7x | 0.88x | 1.79x | 1.42x | 1.05x | 1.27x | 1.22x | 1.17x |
| PEG | - | 0x | -1x | 0x | -1.7x | 6.3x | 0x | 0.5x |
| Capitalization / Revenue | 1.08x | 2.11x | 1.54x | 1.26x | 0.91x | 1x | 0.97x | 0.93x |
| EV / Revenue | 1.33x | 1.77x | 1.74x | 1.49x | 1.11x | 1.29x | 1.23x | 1.14x |
| EV / EBITDA | 9.42x | 5.01x | 8.78x | 7.75x | 6.73x | 7.93x | 7.2x | 6.44x |
| EV / EBIT | 15.1x | 23.8x | 12.8x | 11.2x | 10.5x | 12.3x | 10.6x | 9.16x |
| EV / FCF | 51.5x | 24.6x | 32.2x | 32.6x | 22.7x | 21.9x | 19.6x | 15.5x |
| FCF Yield | 1.94% | 4.06% | 3.1% | 3.07% | 4.41% | 4.57% | 5.1% | 6.46% |
| Dividend per Share 2 | 0.06 | 0.033 | 0.036 | 0.043 | 0.034 | 0.0232 | 0.0256 | 0.0298 |
| Rate of return | 1.74% | 1.4% | 2.12% | 3.23% | 3.52% | 2.04% | 2.24% | 2.61% |
| EPS 2 | 0.089 | -0.624 | 0.018 | 0.037 | 0.007 | 0.0085 | 0.0445 | 0.0607 |
| Distribution rate | 67.4% | -5.29% | 200% | 116% | 486% | 274% | 57.4% | 49.1% |
| Net sales 1 | 959.7 | 337.9 | 316.3 | 302.4 | 302 | 324.3 | 333.4 | 348.3 |
| EBITDA 1 | 135.1 | 119.5 | 62.7 | 58 | 49.9 | 52.84 | 56.88 | 61.97 |
| EBIT 1 | 84 | 25.1 | 43.2 | 40.1 | 32 | 34.08 | 38.73 | 43.55 |
| Net income 1 | 26.9 | -183.8 | 5.4 | 10.6 | 2.1 | 2.2 | 13.39 | 16.67 |
| Net Debt 1 | 234.7 | -113.8 | 62.5 | 68.2 | 60.7 | 95.76 | 86.47 | 75.54 |
| Reference price 2 | 3.450 | 2.365 | 1.696 | 1.330 | 0.966 | 1.140 | 1.140 | 1.140 |
| Nbr of stocks (in thousands) | 300,821 | 301,047 | 287,918 | 286,708 | 284,712 | 283,587 | - | - |
| Announcement Date | 3/18/22 | 3/29/23 | 3/19/24 | 3/19/25 | 3/17/26 | - | - | - |
1GBP in Million2GBP
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 16.67x | - | - | - | 15.23B | ||
| 23.48x | 2.91x | 12.75x | 1.95% | 10.35B | ||
| 333.74x | 70.94x | 235.92x | 0.11% | 9.45B | ||
| 19.81x | 2.3x | 10.14x | -.--% | 7.15B | ||
| 94.34x | 30.75x | 77.68x | 0.24% | 6.52B | ||
| 19.05x | 1.76x | 10.34x | 2.09% | 6.46B | ||
| 114.04x | 8.7x | 36.29x | 0.32% | 4.3B | ||
| 46.37x | 4.84x | 22.42x | 0.74% | 4.24B | ||
| 26.5x | - | - | - | 2.75B | ||
| Average | 77.11x | 17.46x | 57.94x | 0.78% | 7.38B | |
| Weighted average by Cap. | 79.60x | 20.35x | 67.21x | 0.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ESNT Stock
- FLRAF Stock
- Valuation Essentra plc
Select your edition
All financial news and data tailored to specific country editions
















